Paid Clinical Trials in Henderson, NV
As of August 2026, 54 paid clinical trials are recruiting in Henderson, Nevada. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Henderson offers studies at sites including Comprehensive Cancer Centers of Nevada - Henderson for conditions such as Malignant Solid Neoplasm, Breast Cancer, Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Henderson
Trials by drug in Henderson
Filter results
Newly added in Henderson
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
49 clinical trials
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Pelacarsen Roll-over Extension Program
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Mobile Health for Adherence in Breast Cancer Patients
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Project: Every Child for Younger Patients With Cancer
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Top Research Study Locations in Henderson
Researchers run research studies in Henderson, NV at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Comprehensive Cancer Centers of Nevada - Henderson | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Acute Lymphoblastic Leukemia | 24 |
| Comprehensive Cancer Centers of Nevada-Southeast Henderson | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Acute Lymphoblastic Leukemia | 21 |
| Urology Specialists of Nevada - Green Valley | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Acute Lymphoblastic Leukemia | 21 |
| Comprehensive Cancer Centers of Nevada-Horizon Ridge | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Acute Lymphoblastic Leukemia | 20 |
| Oncology Las Vegas - Henderson | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 16 |
| Las Vegas Urology - Pebble | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Adrenal Gland Pheochromocytoma | 14 |
| Las Vegas Urology - Green Valley | Anatomic Stage IV Breast Cancer AJCC v8, Malignant Solid Neoplasm, Anatomic Stage I Breast Cancer AJCC v8 | 13 |
| Cancer and Blood Specialists-Henderson | Anatomic Stage IV Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 10 |
| OptumCare Cancer Care at Seven Hills | Non-Hodgkin Lymphoma, Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma | 10 |
| Comprehensive Cancer Centers of Nevada | Breast Cancer, Chronic Lymphocytic Leukemia, Myelodysplastic Syndromes | 5 |
| Henderson Clinical Trials | Asthma, Interstitial Lung Diseases, Moderate to Severe Chronic Obstructive Pulmonary Disease | 5 |
| GenesisCare USA - Henderson | Anatomic Stage IV Breast Cancer AJCC v8, Elevated CA15-3 or CEA or CA27-29, Estrogen Receptor Positive | 4 |
| Henderson, Nevada | Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2 | 2 |
| Comprehensive & Interventional Pain Management | Lumbar Spinal Stenosis | 1 |
| DaVita Clinical Research - Henderson | End Stage Kidney Disease | 1 |
| Desert Clinical Research, LLC | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 1 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive | 1 |
| Hendersen, Navada | Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2 | 1 |
| Las Vegas Endocrinology | Atherosclerotic Cardiovascular Disease | 1 |
| Mohtaseb Cancer Center and Blood Disorders | MF, Myelofibrosis, Post-ET Myelofibrosis | 1 |
| Nevada State University | Control Condition, Stress | 1 |
| PAS Research - Henderson | COVID 19, Influenza B, Influenza a | 1 |
| Pulmonology Group - Henderson | Dermatitis Atopic | 1 |
| Xena Health | Bacterial Vaginosis, Cancer, Candidiasis | 1 |
Active & Upcoming Studies in Henderson (2026)
Recruiting trials in Henderson grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (24 active studies)
- Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · Phase 3 · Revolution Medicines, Inc.
- A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. · Phase 3 · Pfizer
Vaccines (1 active study)
Diabetes & metabolic (1 active study)
Cardiovascular (1 active study)
Common conditions studied in Henderson
- Malignant Solid Neoplasm (4 active studies)
- Breast Cancer (3 active studies)
- Anatomic Stage IV Breast Cancer AJCC v8 (2 active studies)
- Breast Carcinoma (2 active studies)
- Chronic Lymphocytic Leukemia (2 active studies)
- Idiopathic Hypersomnia (2 active studies)
Leading research sponsors in Henderson
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- AstraZeneca
- ECOG-ACRIN Cancer Research Group
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Henderson?
There are approximately 54 recruiting clinical trials in Henderson, Nevada listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Henderson pay participants?
Most recruiting trials in Henderson compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Henderson?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Henderson?
The most common conditions under active study in Henderson include Malignant Solid Neoplasm (4), Breast Cancer (3), Anatomic Stage IV Breast Cancer AJCC v8 (2), Breast Carcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Henderson?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Henderson on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Henderson?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Henderson?
Recruiting research sites in Henderson include Comprehensive Cancer Centers of Nevada - Henderson, Comprehensive Cancer Centers of Nevada-Southeast Henderson, Urology Specialists of Nevada - Green Valley, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Henderson right now?
The largest active categories in Henderson are Cancer & tumors (24), Vaccines (1), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.